Roles of interleukin-18 in tissue destruction and compensatory reactions

Journal of Immunotherapy

Volumn 25, Issue SUPPL. 1, 2002, Pages

  Kashiwamura, Shin Ichiro ^a   Ueda, Haruyasu ^a   Okamura, Haruki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Compensatory pathway; Destructive pathway; Host defense; Inflammation; Interleukin 18; PGE2; ROI

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; HOST RESISTANCE; INFLAMMATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TISSUE DEGENERATION;

ANIMALS; CELLS, CULTURED; CULTURE TECHNIQUES; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INTERLEUKIN-18; MICE; RECEPTORS, INTERLEUKIN; SENSITIVITY AND SPECIFICITY; TH1 CELLS;

EID: 0036196335     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200203001-00002     Document Type: Conference Paper

References (60)

1. Cloning of a new cytokine that induces IFN-γ production by T cells
2. A novel costimulatory factor for gamma interferon induction found in the liver of mice causes endotoxin shock
3. Interleukin-18: A novel cytokine that augments both innate and acquired immunity
4. Regulation of IL-18 (IFN-γ-inducing factor) gene expression
5. Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression
6. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation
7. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production
8. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme
9. Nitric oxide prevents IL-1β and IFN-γ-inducing factor (IL-18) release from macrophages by inhibiting caspase- 1(IL-1β-converting enzyme)
10. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice
11. Interleukin-18 and interleukin-1β: Two cytokine substrates for ICE (caspase-1)
12. The human interleukin 18 gene maps to 1 1q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci
13. IL-1RrP is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP
14. Purification and characterization of the human interleukin-18 receptor
15. Generation of IL-18 receptor-deficient mice: Evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor
16. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells and B cells: Synergism with IL-18 for IFN-γ production
17. 4+ T lymphocytes
18. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement
19. Interaction of NF-κB and NFAT with the interferon-γ promoter
20. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain
21. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses
22. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
23. Defective NK cell activity and Th1 response in IL-18-deficient mice
24. IL-18 is a potent inducer of IL-13 in NK and T cells: A new potential role for IL-18 in modulating the immune response
25. + T cells, 11-4 and STAT6
26. Fas/Fas ligand interaction promote activation-induced cell death on NK T lymphocytes
27. Decreased expression of cytokines that induce type 1 helper T cell / interferon-γ responses in genetically susceptible mice infected with Mycobacterium avium
28. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium
29. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: Correlation with interferon-gamma (IFN-γ) production
30. IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice
31. Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri-induced inflammation
32. Chlamydia trachomatis infection of epithelial cells induces the activation of caspase-1 and release of mature IL-18
33. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection
34. Influenza A virus-induced IFN-α/β and IL-18 synergistically enhance IFN-γ gene expression in human T cells
35. In vivo anti-viral effect of interleukin 18 in a mouse model of vaccinia virus infection
36. Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection
37. In vivo antitumor effect of murine interferon-γ-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites
38. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma
39. Neuroblastoma cells expressing mature IL-18, but not pro IL-18, induce a strong and immediate antitumor immune response
40. Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by testament with interleukin-18
41. Antitumor activity of interleukin-18 on mouse glioma cells
42. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells
43. Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model
44. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells
45. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates
46. Pathophysiological roles of interleukin-18 for inflammatory liver diseases
47. IFN-γ-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12
48. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ-dependent manner
49. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against Escherichia coli and Salmonella typhimurium endotoxemia
50. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils
51. Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice
52. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis
53. + human blood mononuclear cells
54. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock
55. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression
56. A new view of prostaglandin E regulation of the immune response
57. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses
58. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis
59. The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells
60. IL-18 in pregnancy; the elevation of IL-18 in maternal peripheral blood during labor and complicated pregnancies